CD47 and neoplasm: The use of anti-CD47 mAb to control the growth of human tumor xenografts in NOD SCID gammaTM mice was therapeutically efficacious for medulloblastoma, glioblastoma, ovarian, bladder, colorectal and breast tumors [236,237,238].